Eisai Co.’s breakthrough Alzheimer’s disease drug is poised to gain the backing of Japanese regulators after the medicine was fully cleared in the US last month.
A panel that advises Japan’s health ministry recommended approval of Leqembi, according to a government statement Monday. The ministry relies on the expert panel’s review before clearing new medicines and generally follows its recommendations.
Jefferies Japan Ltd. analyst Stephen Barker assumes Japan’s reimbursement to be about ¥2 million per year, according to his note Monday. Eisai is also seeking approval of the medicine in other markets, including Europe and China. The company forecasts revenue from Leqembi to reach ¥1 trillion in fiscal 2030.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Japanese government pledges long-term support for fisheries during Fukushima plant water releaseTOKYO (AP) — Japanese Prime Minister Fumio Kishida on Monday promised his government's full support for fishing communities during the decades-long process to release treated radioactive wastewater from the wrecked Fukushima nuclear plant into the sea. Meeting with fisheries representatives, Kishida promised measures to protect the fishing industry's reputation until the release ends. Masanobu Sakamoto, head of the National Federation of Fisheries Cooperatives, reiterated his organization's oppo
Read more »
Japanese government pledges long-term support for fisheries during Fukushima plant water releaseJapanese government officials sought understanding from fisheries groups Monday for the impending release of treated radioactive wastewater from the wrecked Fukushima nuclear plant into the sea and pledged to support their livelihoods throughout the process that will take decades.
Read more »
BEHIND THE SCENES: The Spot makes its mark on drug toxicity crisisSudbury.com reporter Jenny Lamothe takes us behind the scenes
Read more »
Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturerOn its website, the federal regulator said 'intermittent shortages' are expected from late August to early October
Read more »
With thousands of N.W.T. evacuees in Alberta, local experts fear impact of toxic drug crisisDoctors and advocates are distributing information for N.W.T. wildfire evacuees, telling them where to access opioid agonist therapies in Alberta. Amid the toxic drug crisis, they fear stigma and a lack of information could increase drug poisonings and deaths.
Read more »
Japan's Kishida to meet fishermen on Fukushima water release planTOKYO (Reuters) - Japanese Prime Minister Fumio Kishida said he will meet fishermen as soon as Monday to seek their understanding of the government's ...
Read more »